Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × ruxolitinib × 30 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 5 Thrombocythemia, Essential 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Polycythemia Vera 2 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Leukemia 2 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Graft vs Host Disease 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 6 fludarabine 6 Whole-Body Irradiation 5 Mycophenolic Acid 4 asciminib 3 Mesna 3 Melphalan 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Dasatinib 3 nilotinib 2 bosutinib 2 Tacrolimus 2 Stem Cell Transplantation 2 Cyclosporine 2 Busulfan 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ponatinib 1 blinatumomab 1 aldesleukin 1 Thiotepa 1 Succimer 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡